CALI: CalciMedica Corp O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
CalciMedica, Inc. (CALI) hozirda klinik sinovlar bosqichida bo'lib, bu uning daromadlarini vaqtincha cheklaydi. Biroq, noyob Auxora dori vositasi intensiv terapiya bo'limlarida sezilarli narx belgilash imkoniyatini taqdim etadi. O'sish 2026-yilga qadar pankreatit bo'yicha yangi ma'lumotlar va sherikliklar hisobiga amalga oshishi kutilmoqda. Joriy PEG koeffitsiyenti foydaga nisbatan kapitalizatsiya dinamikasini aks ettiradi va uning hozirgi qiymati 0.00 ni tashkil etadi.
CalciMedica, Inc. (CALI) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati CalciMedica, Inc.|CALI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi calcimedica.com|CALI - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar CalciMedica Corp|CALI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari CalciMedica|Tezkor likvidlik koeffitsiyenti calcimedica.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CALI - Kompaniyaning sof foydasi|Kutilayotgan foyda CalciMedica, Inc.|CALI - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati calcimedica.com|CALI - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati CalciMedica Corp|CALI - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda CalciMedica|CALI - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi calcimedica.com|CALI - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati CalciMedica, Inc.
Kompaniyaning umumiy tahlili:CALI - CalciMedica Inc
Investor aktivning xavfsizlik zaxirasini P/E bozor koeffitsientini foyda o'sish sur'atlari bilan solishtirish orqali aniqlaydi, bunda birdan past qiymat fundamental past baholanganlikdan dalolat beradi. CalciMedica, Inc. (CALI) uchun patentlangan dori vositalarining yuqori masshtablanuvchanligi va past sintez xarajatlarining uyg'unligi joriy PEG koeffitsientini biotexnologiya segmentidagi bozor kapitalizatsiyasi o'sish potentsialining asosiy ko'rsatkichiga aylantiradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|Pharvaris Pharma (PHVS) - Narx-foyda va o‘sish multiplikatori|ABCL: PEG multiplikatori|tourmalinebio.com (TRML) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Precigen|Narxning foydaga va o‘sish sur’atiga nisbati PHAR|PEG multiplikatori NKTR|Narx-foyda va o‘sish multiplikatori Upstream Pharma UPB|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunome.com (IMNM)|GOSS - Narxning foydaga va o‘sish sur’atiga nisbati|KalVista Pharma (KALV) - Narx-foyda va o‘sish multiplikatori|SEPN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Pieris Corp (PVLA)|SVRA (Savara Inc.) - PEG multiplikatori|O‘sishni hisobga olgan narx-foyda koeffitsiyenti RIGL (rigel.com)|PEG multiplikatori ANAB|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Astria Therapeutics Inc|PEG multiplikatori ENGN (enGene Bio)|RAPT - Narx-foyda va o‘sish multiplikatori|Aerovate - PEG multiplikatori|ACRS - PEG multiplikatori|KYTX (Kyverna Therapeutics, Inc.) - Narx-foyda va o‘sish multiplikatori|Tiziana Life Sciences Ltd. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|CABA (Cabaletta Bio, Inc) - PEG multiplikatori|Ventyx Biosciences, Inc (VTYX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Theratechnologies Inc. (THTX)|avalotx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori ELDN (Eledon Pharmaceuticals, Inc.)|AGEN - Narx-foyda va o‘sish multiplikatori|CLYM: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati zurabio.com ZURA|ATYR: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori Adagene Inc.|IMA (ImageneBio) - PEG multiplikatori|PEG multiplikatori Shattuck Therapeutics|Narxning foydaga va o‘sish sur’atiga nisbati Equillium, Inc. (EQ)|Narxning foydaga va o‘sish sur’atiga nisbati CNTB (connectbiopharm.com)|PEG multiplikatori IMUX (Immunic)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Atara Biotherapeutics, Inc. (ATRA)|IFRX - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati XFOR|ACET: PEG multiplikatori|Celularity - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|INMB (INmune Bio, Inc.) - PEG multiplikatori|PEG multiplikatori barinthusbio.com|Narxning foydaga va o‘sish sur’atiga nisbati Kezar Life Sciences, Inc. (KZR)|SABS (SAB Biotherapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Akari Therapeutics plc AKTX|ENLV - Narx-foyda va o‘sish multiplikatori|Q32 Bio Corp - PEG multiplikatori|GOVX - PEG multiplikatori|EDSA (Edesa Biotech) - Narx-foyda va o‘sish multiplikatori|iBio Inc - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|CARM (Carisma Therapeutics Inc) - PEG multiplikatori|XTL Bio (XTLB) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Bolt Biotherapeutics (BOLT)|Narx-foyda va o‘sish multiplikatori hcwbiologics.com HCWB|Narxning foydaga va o‘sish sur’atiga nisbati Aptevo Therapeutics Inc. APVO|AIM - Narx-foyda va o‘sish multiplikatori|ADTX: Narx-foyda va o‘sish multiplikatori|GRI - PEG multiplikatori|XORTX Therapeutics Inc. (XRTX) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti HIND|REVB (Revelation Biosciences, Inc.) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Indaptus Therapeutics Inc INDP|PEG multiplikatori SCNI|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|PEG multiplikatori ALLK (Allakos)|PEG multiplikatori HOOKIPA Pharma, Inc. HOOK|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|ITOS: Narxning foydaga va o‘sish sur’atiga nisbati|OCEA: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori TC BioPharm Ltd|THRD (Third Harmonic Bio) - PEG multiplikatori
